Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2016

01.08.2016 | Research Article

Patient and medication-related factors associated with hospital-acquired hyponatremia in patients hospitalized from heart failure

verfasst von: S. Saepudin, Patrick A. Ball, Hana Morrissey

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background Hyponatremia has been known as an important predictor of clinical outcomes in patients with heart failure (HF). While information on hyponatremia in patients with HF has been available abundantly, information on factors associated with increased risk of developing hospital-acquired hyponatremia (HAH) is still limited. Objective To identify patients and medication-related factors associated with HAH in patients hospitalized from HF. Setting Fatmawati Hospital in Jakarta, Indonesia. Methods This is a nested case–control study with patients developing HAH served as case group and each patient in case group was matched by age and gender to three patients in control group. Patients included in this study are patients hospitalized from HF, and coded with I.50 according to ICD-10, during 2011–2013 at Fatmawati Hospital in Jakarta, Indonesia. Information retrieved from patients’ medical records included demographic profiles, vital signs and symptoms at admission, past medical history, medication during hospitalization and clinical chemistry laboratory records. Multivariable logistic regression analysis was performed to find out patient and treatment-related factors associated with the development of HAH. Main outcome measures Patients and medication related factors having significant association with HAH. Results Four hundreds sixty-four patients were included in this study and 45 of them (9.7 %) met criteria of developing HAH so then, accordingly, 135 patients were selected as controls. 36 patient- and 22 treatment-related factors were analyzed in univariate logistic regression resulted in 20 factors having p value <0.2 and were included in multivariable logistic regression analysis. Final factors showing significant association with HAH are presence of ascites at admission (odds ratio = 4.7; 95 % confidence interval 1.9–11.5) and administration of amiodarone (3.2; 1.3–7.4) and heparin (3.1; 1.2–7.3) during hospital stay. Conclusion Presence of ascites at admission was found as patient-related factors associated with HAH in this study. In addition, administration of amiodarone and heparin during hospital stay were found as medication-related factors associated with HAH in patients hospitalized from HF.
Literatur
1.
Zurück zum Zitat Sato N, Gheorghiade M, Kajimoto K, Munakata R, Minami Y, Mizuno M, Aokage T, Asai K, Sakata Y, Yumino D, et al. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol. 2013;111(7):1019–25.CrossRefPubMed Sato N, Gheorghiade M, Kajimoto K, Munakata R, Minami Y, Mizuno M, Aokage T, Asai K, Sakata Y, Yumino D, et al. Hyponatremia and in-hospital mortality in patients admitted for heart failure (from the ATTEND registry). Am J Cardiol. 2013;111(7):1019–25.CrossRefPubMed
2.
Zurück zum Zitat Saepudin S, Ball PA, Morrissey H. Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure. BMC Cardiovasc Disord. 2015;15:88.CrossRefPubMedPubMedCentral Saepudin S, Ball PA, Morrissey H. Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure. BMC Cardiovasc Disord. 2015;15:88.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hauptman PJ. Clinical challenge of hyponatremia in heart failure. J Hosp Med. 2012;7(Suppl 4):S6–10.CrossRefPubMed Hauptman PJ. Clinical challenge of hyponatremia in heart failure. J Hosp Med. 2012;7(Suppl 4):S6–10.CrossRefPubMed
4.
Zurück zum Zitat Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40(10):1801–8.CrossRefPubMed Kearney MT, Fox KAA, Lee AJ, Prescott RJ, Shah AM, Batin PD, Baig W, Lindsay S, Callahan TS, Shell WE, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40(10):1801–8.CrossRefPubMed
6.
Zurück zum Zitat Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4(4):389–98.CrossRefPubMedPubMedCentral Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4(4):389–98.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21(1):70–6.CrossRefPubMed Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21(1):70–6.CrossRefPubMed
8.
Zurück zum Zitat Thompson C, Hoorn EJ. 1 Hyponatraemia: an overview of frequency, clinical presentation and complications. Best Pract Res Clin Endocrinol Metab. 2012;26:S1–6.CrossRefPubMed Thompson C, Hoorn EJ. 1 Hyponatraemia: an overview of frequency, clinical presentation and complications. Best Pract Res Clin Endocrinol Metab. 2012;26:S1–6.CrossRefPubMed
9.
Zurück zum Zitat Bettari L, Fiuzat M, Shaw LK, Wojdyla DM, Metra M, Felker GM, O’Connor CM. Hyponatremia and long-term outcomes in chronic heart failure—an observational study from the Duke Databank for Cardiovascular Diseases. J Card Fail. 2012;18(1):74–81.CrossRefPubMed Bettari L, Fiuzat M, Shaw LK, Wojdyla DM, Metra M, Felker GM, O’Connor CM. Hyponatremia and long-term outcomes in chronic heart failure—an observational study from the Duke Databank for Cardiovascular Diseases. J Card Fail. 2012;18(1):74–81.CrossRefPubMed
10.
Zurück zum Zitat Essebag V, Genest J, Suissa S, Pilote L. The nested case–control in cardiology. Am Heart J. 2003;146(4):581–90.CrossRefPubMed Essebag V, Genest J, Suissa S, Pilote L. The nested case–control in cardiology. Am Heart J. 2003;146(4):581–90.CrossRefPubMed
11.
Zurück zum Zitat Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes A, Grobbee DE, Moons KG. Advantages of the nested case–control design in diagnostic research. BMC Med Res Methodol. 2008;8(48):1–7. Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes A, Grobbee DE, Moons KG. Advantages of the nested case–control design in diagnostic research. BMC Med Res Methodol. 2008;8(48):1–7.
12.
Zurück zum Zitat Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Novel risk factors for hospital-acquired hyponatremia: a matched case–control study. Clin Endocrinol (Oxf). 2007;66(3):367–72.CrossRef Beukhof CM, Hoorn EJ, Lindemans J, Zietse R. Novel risk factors for hospital-acquired hyponatremia: a matched case–control study. Clin Endocrinol (Oxf). 2007;66(3):367–72.CrossRef
13.
Zurück zum Zitat Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294–302.CrossRefPubMed Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294–302.CrossRefPubMed
14.
Zurück zum Zitat Shchekochikhin DY, Schrier RW, Lindenfeld J, Price LL, Jaber BL, Madias NE. Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure. Circ Heart Fail. 2013;6(3):379–86.CrossRefPubMed Shchekochikhin DY, Schrier RW, Lindenfeld J, Price LL, Jaber BL, Madias NE. Outcome differences in community- versus hospital-acquired hyponatremia in patients with a diagnosis of heart failure. Circ Heart Fail. 2013;6(3):379–86.CrossRefPubMed
15.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey DE Jr, McMurray JJ, Drazner MH, Mitchell JE, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.CrossRefPubMed
16.
Zurück zum Zitat Rai A, Whaley-Connell A, McFarlane S, Sowers JR. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism. Am J Nephrol. 2006;26(6):579–89.CrossRefPubMed Rai A, Whaley-Connell A, McFarlane S, Sowers JR. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism. Am J Nephrol. 2006;26(6):579–89.CrossRefPubMed
17.
Zurück zum Zitat Ghali JK, Tam SW. The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail. 2010;16(5):419–31.CrossRefPubMed Ghali JK, Tam SW. The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail. 2010;16(5):419–31.CrossRefPubMed
18.
Zurück zum Zitat Doggrell SA. Amiodarone-waxed and waned and waxed again. Expert Opin Pharmacother. 2001;2(11):1877–90.CrossRefPubMed Doggrell SA. Amiodarone-waxed and waned and waxed again. Expert Opin Pharmacother. 2001;2(11):1877–90.CrossRefPubMed
19.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69.CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803–69.CrossRefPubMed
20.
Zurück zum Zitat Dutta P, Parthan G, Aggarwal A, Kumar S, Kakkar N, Bhansali A, Rotondo F, Kovacs K. Amiodarone induced hyponatremia masquerading as syndrome of inappropriate antidiuretic hormone secretion by anaplastic carcinoma of prostate. Case Rep Urol. 2014;2014:136984. doi:10.1155/2014/136984.PubMedPubMedCentral Dutta P, Parthan G, Aggarwal A, Kumar S, Kakkar N, Bhansali A, Rotondo F, Kovacs K. Amiodarone induced hyponatremia masquerading as syndrome of inappropriate antidiuretic hormone secretion by anaplastic carcinoma of prostate. Case Rep Urol. 2014;2014:136984. doi:10.​1155/​2014/​136984.PubMedPubMedCentral
21.
Zurück zum Zitat Pham L, Shaer AJ, Marnejon T. Hyponatremia—a rare but serious complication of amiodarone: a case report and review of the literature. Case Rep Nephrol Urol. 2013;3(1):46–50.CrossRefPubMedPubMedCentral Pham L, Shaer AJ, Marnejon T. Hyponatremia—a rare but serious complication of amiodarone: a case report and review of the literature. Case Rep Nephrol Urol. 2013;3(1):46–50.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Ikagemi H, Shiga T, Tsushima T, Nirei T, Kasanuki H. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases. J Cardiovasc Pharmacol Ther. 2002;7(1):25–8.CrossRef Ikagemi H, Shiga T, Tsushima T, Nirei T, Kasanuki H. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by amiodarone: a report on two cases. J Cardiovasc Pharmacol Ther. 2002;7(1):25–8.CrossRef
23.
Zurück zum Zitat Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;98:575–86.CrossRefPubMed Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;98:575–86.CrossRefPubMed
24.
Zurück zum Zitat Bengalorkar GM, Sarala N, Venkatrathnamma PN, Kumar TN. Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. J Pharmacol Pharmacother. 2011;2(4):266–9.CrossRefPubMedPubMedCentral Bengalorkar GM, Sarala N, Venkatrathnamma PN, Kumar TN. Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels. J Pharmacol Pharmacother. 2011;2(4):266–9.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Norman NE, Sneed AM, Brown C, Ellis CA, Minard G, Brown RO. Heparin-induced hyponatremia. Ann Pharmacother. 2004;38(3):404–7.CrossRefPubMed Norman NE, Sneed AM, Brown C, Ellis CA, Minard G, Brown RO. Heparin-induced hyponatremia. Ann Pharmacother. 2004;38(3):404–7.CrossRefPubMed
26.
Zurück zum Zitat Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo Iii JA, Chiong JR, Dasta JF, Friend KE, Hauptman PJ, Peri A, et al. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 2015;88(1):167–77.CrossRefPubMedPubMedCentral Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo Iii JA, Chiong JR, Dasta JF, Friend KE, Hauptman PJ, Peri A, et al. Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 2015;88(1):167–77.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Nemerovski C, Hutchinson DJ. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Clin Ther. 2010;32(6):1015–32.CrossRefPubMed Nemerovski C, Hutchinson DJ. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review. Clin Ther. 2010;32(6):1015–32.CrossRefPubMed
28.
Zurück zum Zitat Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1–21.CrossRefPubMed Verbalis JG, Goldsmith SR, Greenberg A, Schrier RW, Sterns RH. Hyponatremia treatment guidelines 2007: expert panel recommendations. Am J Med. 2007;120(11 Suppl 1):S1–21.CrossRefPubMed
29.
Zurück zum Zitat Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29(3):282–99.CrossRefPubMed Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia. Semin Nephrol. 2009;29(3):282–99.CrossRefPubMed
Metadaten
Titel
Patient and medication-related factors associated with hospital-acquired hyponatremia in patients hospitalized from heart failure
verfasst von
S. Saepudin
Patrick A. Ball
Hana Morrissey
Publikationsdatum
01.08.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0296-3

Weitere Artikel der Ausgabe 4/2016

International Journal of Clinical Pharmacy 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.